Award-winning researcher, Dr. Doruk Erkan, discusses new classification criteria for Antiphospholipid Syndrome (APS), highlighting the challenges of diagnosis and the need for further research. The podcast explores the complexity of APS, emphasizes the importance of assessing the antiphospholipid antibody profile, and discusses the limitations of the old criteria. The development of the new classification criteria is discussed, emphasizing the collaborative effort and point-based system. The podcast also touches on the challenges of APS guidelines, the development of criteria for patients needing anticoagulation, and the potential impact on diagnosis and management of ANIFOSFELIPIT syndrome.
